KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Is the serum creatinine/alanine transaminase ratio a predictor of mortality in elderly patients with acute ischemic stroke?
Aims: In recent years, the rate of admission to intensive care in the elderly population has been increasing. We aimed to investigate the relationship between the serum creatinine/alanine transaminase ratio (sCr/ALT), which is thought to be a simpler method for predicting mortality in the elderly patient group instead of intensive care scoring systems that are difficult to calculate, and mortality.
Methods: Medical records of patients treated in the intensive care unit due to acute ischemic stroke between January 2017 and October 2021 were evaluated. The study included 189 patients over the age of 85 who were diagnosed with cerebrovascular disease, had no known liver or kidney disease, and had a creatinine value of <1.5 mg/dl. APACHE II, SAPS II, and NIHSS scores calculated during admission to the intensive care unit were calculated from system data and patient records. Demographic data, additional diseases, hospital stay, laboratory values, sCr/ALT ratios and 28-day mortality status of the patients were recorded.
Results: In a total of 189 patients, 66 male and 123 female, included in the study, mortality occurred at a rate of 65.1% (n: 123) in the first 28 days. The presence of coronary artery disease (p=0.044) was significantly higher in mortal cases. There were statistically significant differences in APACHE II score (p<0.001), SAPS II (p<0.001), AST (p=0.008), creatinine (p<0.001), sCr/ALT ratio (p<0.001), neutrophil/lymphocyte ratio (p=0.049), ferritin (p=0.003) and CRP (p=0.006) in mortal cases and non-mortals. In mortal cases, NIHSS severe (p<0.001) percentage was significantly higher than in other patients. ALT (p<0.001), lymphocyte (p=0.009) and albumin (p<0.001) values were statistically significantly lower in mortal cases than in non-mortals. When we evaluated the 28-day mortality prediction performances of the variables, the sCr/ALT ratio was found to have 85.4% sensitivity and 84.8% specificity, the albumin value had 85.4% sensitivity and 60.6% specificity, and the APACHE II score had 61.8% sensitivity and 90.9% specificity .
Conclusion: NIHSS, APACHI II and SAPS II are used as mortality and disease severity indicators in elderly intensive care patients with acute ischemic stroke. When compared with these scores, the sCr/ALT value is a valuable indicator in predicting mortality. We found that the sCr/ALT ratio, which is easily worked on and calculated in many centers, can better predict mortality in elderly patients with ischemic stroke.


1. Ageing and Health. Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. [cited April 26, 2022].
2. Formiga F, Ferrer A, Padros G, Montero A, Gimenez-Argente C, Corbella X. Evidence of functional declining and global comorbidity measured at baseline proved to be the strongest predictors for long-term death in elderly community residents aged 85 years: a 5-year follow-up evaluation, the OCTABAIX study. Clin Interv Aging. 2016;11:437-444. doi:10.2147/CIA.S101447
3. C&oacute;rdoba J, O&rsquo;Riordan K, Dupuis J, Borensztajin J, Blei AT. Diurnal variation of serum alanine transaminase activity in chronic liver disease. Hepatology. 1998;28(6):1724-1725. doi:10.1002/hep.510280640
4. Schmilovitz-Weiss H, Gingold-Belfer R, Grossman A, et al. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly. PLoS One. 2019;14(4):e0212737. doi:10.1371/journal.pone.0212737
5. Schmilovitz-Weiss H, Gingold-Belfer R, Boltin D, et al. Risk of mortality and level of serum alanine aminotransferase among community-dwelling elderly in Israel. Eur J Gastroenterol Hepatol. 2018;30(12):1428-1433. doi:10.1097/MEG.0000000000001225
6. Brigden ML, Heathcote JC. Problems in interpreting laboratory tests. What do unexpected results mean? Postgrad Med. 2000;107:7. doi:10. 3810/pgm.2000.06.1127
7. Walker HK, Hall WD, Hurst JW, eds. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990.
8. Carter B, Ramsay EA, Short R, et al. Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study. BMC Geriatr. 2022;22(1):119. doi:10.1186/s12877-022-02782-5
9. Weng SC, Chen CM, Chen YC, Wu MJ, Tarng DC. Trajectory of estimated glomerular filtration rate and malnourishment predict mortality and kidney failure in older adults with chronic kidney disease. Front Med (Lausanne). 2021;8:760391. doi:10.3389/fmed.2021.760391
10. Portegies ML, Koudstaal PJ, Ikram MA. Cerebrovascular disease. Handb Clin Neurol. 2016;138:239-261. doi:10.1016/B978-0-12-802973-2.00014-8
11. Walker RW, McLarty DG, Masuki G, et al. Age specific prevalence of impairment and disability relating to hemiplegic stroke in the Hai District of northern Tanzania. Adult morbidity and mortality project. J Neurol Neurosurg Psychiatry. 2000;68(6):744-749. doi:10.1136/jnnp.68.6. 744
12. Krasselt M, Baerwald C, Petros S, Seifert O. Sepsis mortality is high in patients with connective tissue diseases admitted to the intensive care unit (ICU). J Intensive Care Med. 2022;37(3):401-407. doi:10.1177/ 0885066621996257
13. Moreno-Torres V, Royuela A, M&uacute;&ntilde;ez E, et al. Better prognostic ability of NEWS2, SOFA and SAPS-II in septic patients. Mejor capacidad pron&oacute;stica de NEWS2, SOFA y SAPS-II en pacientes con sepsis. Med Clin (Barc). 2022;159(5):224-229. doi:10.1016/j.medcli.2021.10.021
14. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989;20(10):1407-1431. doi:10.1161/01.str.20.10.1407
15. Kr&oacute;lczyk J, Skalska A, Piotrowicz K, Mossakowska M, Grodzicki T, Gasowski J. Disparate effects of Ankle-Brachial Index on mortality in the &lsquo;very old&rsquo; and &lsquo;younger old&rsquo; populations-the PolSenior survey. Heart Vessels. 2022;37(4):665-672. doi:10.1007/s00380-021-01949-1
16. An SJ, Yang YJ, Jeon NM, Hong YP, Kim YI, Kim DY. Significantly reduced alanine aminotransferase level increases all-cause mortality rate in the elderly after ischemic stroke. Int J Environ Res Public Health. 2021;18(9):4915. doi:10.3390/ijerph18094915
17. Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensiv Care Med. 2010;36(10):1657-1665. doi:10.1007/s00134-010-1928-z
18. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75(6):652-660. doi:10.1038/ki.2008.638
19. Ren C, Su H, Tao J, Xie Y, Zhang X, Guo Q. Sarcopenia Index based on serum creatinine and Cystatin C is associated with mortality, nutritional risk/malnutrition and sarcopenia in older patients. Clin Interv Aging. 2022;17:211-221. doi:10.2147/CIA.S351068
20. Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, Stessman J. Low alanine aminotransferase activity in older people is associated with greater long-term mortality. J Am Geriatr Soc. 2006;54(11):1719-1724. doi:10.1111/j.1532-5415.2006.00921.x
21. Dong MH, Bettencourt R, Brenner DA, Barrett-Connor E, Loomba R. Serum levels of alanine aminotransferase decrease with age in longitudinal analysis. Clin Gastroenterol Hepatol. 2012;10(3):285-90.e1. doi:10.1016/j.cgh.2011.10.014
22. Weber Y, Epstein D, Miller A, Segal G, Berger G. Association of low alanine aminotransferase values with extubation failure in adult critically ill patients: a retrospective cohort study. J Clin Med. 2021; 10(15):3282. doi:10.3390/jcm10153282
23. Itelman E, Segev A, Ahmead L, et al. Low ALT values amongst hospitalized patients are associated with increased risk of hypoglycemia and overall mortality: a retrospective, big-data analysis of 51 831 patients. QJM. 2022;114(12):843-847. doi:10.1093/qjmed/hcaa219 </ol> <p>
Volume 5, Issue 2, 2025
Page : 123-127
_Footer